| Malignant Peritoneal Neoplasm studied in …STUDIED_INderived200 of 502show all (up to 200) |
|---|
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776691Phase 3 · recruiting A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708753Phase 3 · recruiting A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001880Phase 2 · recruiting Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05446298Phase 2 · active not recruiting ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495124Phase 2 · recruiting IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00515372Phase 1 · active not recruiting Depression Treatment and Screening in Ovarian Cancer Patients · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080946early Phase 1 · suspended Using Aspirin to Improve Immunological Features of Ovarian Tumors · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915025Phase 3 · recruiting Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012817Phase 1/Phase 2 · active not recruiting Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743164Phase 3 · not yet recruiting A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595892Phase 2 · active not recruiting Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492070Phase 2 · recruiting Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034927Phase 2 · active not recruiting Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Sensitive Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355976Phase 2 · active not recruiting BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04673448Phase 1 · active not recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604315Phase 1 · recruiting Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415709early Phase 1 · active not recruiting Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02217956Phase 1 · completed Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943173early Phase 1 · active not recruiting Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00488878recruiting Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114421Phase 2 · active not recruiting Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03026062Phase 2 · completed Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07653594NA · not yet recruiting TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101788Phase 2/Phase 3 · completed Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554328Phase 2 · active not recruiting Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627443Phase 1 · active not recruiting Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616534Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05460000Phase 2 · recruiting A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022213Phase 2 · active not recruiting A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469764Phase 2 · recruiting Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113487Phase 2 · active not recruiting P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03579316Phase 2 · active not recruiting Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092373Phase 1 · recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465941Phase 2 · active not recruiting PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887609Phase 2 · recruiting An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650986Phase 1/Phase 2 · active not recruiting Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587311Phase 2 · active not recruiting Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429970NA · recruiting A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674615Phase 1 · not yet recruiting IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387227Phase 2 · completed Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071937Phase 2 · recruiting ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538091Phase 2 · recruiting Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055649Phase 2 · recruiting ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04027868completed Genomic BRCA and Extensive ovArian Cancer Testing · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05445778Phase 3 · active not recruiting Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730347Phase 2 · recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07617753Phase 1/Phase 2 · recruiting Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03430700Phase 2 · completed Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04701645Phase 1 · recruiting Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295577completed Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04314401active not recruiting National Cancer Institute "Cancer Moonshot Biobank" · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691504Phase 1 · active not recruiting Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05271318Phase 1/Phase 2 · active not recruiting Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06295965recruiting Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02659241early Phase 1 · active not recruiting Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06274541completed Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516447Phase 1 · recruiting A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017131Phase 1 · active not recruiting Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05335993Phase 2 · active not recruiting A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02873962Phase 2 · active not recruiting A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498117Phase 3 · active not recruiting Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290193Phase 2 · recruiting Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06969833NA · recruiting Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02758951Phase 2/Phase 3 · active not recruiting Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04095364Phase 3 · active not recruiting Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198804Phase 1/Phase 2 · completed A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480954Phase 1/Phase 2 · recruiting Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726330NA · not yet recruiting Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06144853completed The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483048Phase 1 · recruiting MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968406Phase 1 · recruiting Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06184867NA · completed Choices About Genetic Testing And Learning Your Risk With Smart Technology · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970722Phase 1 · active not recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05527184Phase 1 · active not recruiting First in Human Study of IMGN151 in Recurrent Gynaecological Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781088Phase 2 · active not recruiting Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469281Phase 1 · recruiting A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483997active not recruiting Diet, Hepcidin, and Chemotherapy RDI · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041257Phase 2 · completed Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04204811NA · active not recruiting Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855706NA · recruiting An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565851Phase 3 · active not recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483933Phase 1 · completed Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269574not yet recruiting Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06870539completed Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236686NA · recruiting Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03325634Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084416Phase 1 · active not recruiting A Study of Sovilnesib in Subjects With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03776812Phase 2 · completed Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05200364Phase 1 · terminated A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03029403Phase 2 · active not recruiting Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06451263NA · active not recruiting Nudge to Gynecologic Oncology · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009082Phase 3 · recruiting Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449366Phase 1/Phase 2 · completed Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498600Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767675Phase 2 · completed Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04209855Phase 3 · completed A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03748186Phase 1 · completed Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708924Phase 1 · terminated MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04611126Phase 1/Phase 2 · terminated T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05406674Phase 2 · active not recruiting Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022535Phase 2 · recruiting Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07023484Phase 2 · recruiting Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05274451Phase 1 · terminated A Study to Investigate LYL797 in Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891197terminated A Biomarker Screening Protocol for Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06602063Phase 1/Phase 2 · not yet recruiting Surgery for Relapsed Ovarian Cancer in Precision · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05788484Phase 1 · completed A Study of CDX-585 in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783949Phase 2 · completed European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019288Phase 1/Phase 2 · terminated AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06087289Phase 1/Phase 2 · completed A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02419495Phase 1 · terminated Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07001592Phase 1 · recruiting Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713386Phase 1/Phase 2 · completed Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575961Phase 2 · active not recruiting Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672095Phase 1/Phase 2 · withdrawn Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02470299NA · completed Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03508570Phase 1 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06972693Phase 4 · active not recruiting NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756130Phase 1/Phase 2 · withdrawn Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05179824active not recruiting Tempus Priority Study: A Pan-tumor Observational Study · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02569957Phase 2 · terminated Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471483completed Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03585764Phase 1 · terminated MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206047Phase 1/Phase 2 · completed Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06867562Phase 3 · not yet recruiting Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04196257Phase 1 · recruiting BP1001-A in Patients With Advanced or Recurrent Solid Tumors · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05591131NA · active not recruiting Genetic Testing in African Americans · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04213794early Phase 1 · terminated Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05737303Phase 3 · recruiting Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02859038Phase 3 · active not recruiting Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05200260Phase 2 · recruiting Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04406623Phase 1 · completed Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891576Phase 2 · terminated Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735326Phase 2 · recruiting Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02312245Phase 2 · completed Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276574active not recruiting Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05718726recruiting Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124421Phase 2 · active not recruiting HOT: HIPEC in Ovarian Cancer as Initial Treatment · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953457Phase 2 · completed Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05261490Phase 1/Phase 2 · terminated Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199272Phase 1/Phase 2 · active not recruiting A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907527Phase 1 · active not recruiting Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648489Phase 2 · completed Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03691376Phase 1 · terminated Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06599749completed Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445275withdrawn Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01606241Phase 1 · completed Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05597683NA · unknown Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03539406Phase 1 · completed Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04296890Phase 3 · completed A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543069Phase 2 · recruiting Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM · condition mapped CURATED_BROADER · 502 trials mapped (133 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344095Phase 1 · completed A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04257045completed Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445621unknown Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126812Phase 1/Phase 2 · completed Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420973Phase 2 · recruiting RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02668913NA · completed LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676334Phase 3 · completed CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib · condition mapped ALIAS · 502 trials mapped (133 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538624Phase 1/Phase 2 · terminated A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary · condition mapped ONTOLOGY_EXACT · 502 trials mapped (133 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |